1. Home
  2. FBGL vs XRTX Comparison

FBGL vs XRTX Comparison

Compare FBGL & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FBS Global Limited Ordinary Shares

FBGL

FBS Global Limited Ordinary Shares

HOLD

Current Price

$2.25

Market Cap

4.8M

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$0.97

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBGL
XRTX
Founded
1996
2011
Country
Singapore
Canada
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
3.9M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
FBGL
XRTX
Price
$2.25
$0.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
104.8K
★ 346.0K
Earning Date
11-23-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$392.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.35
52 Week High
$4.30
$3.60

Technical Indicators

Market Signals
Indicator
FBGL
XRTX
Relative Strength Index (RSI) 48.81 28.81
Support Level $0.43 $0.37
Resistance Level $4.30 $2.26
Average True Range (ATR) 0.26 0.22
MACD -0.21 -0.07
Stochastic Oscillator 14.31 2.73

Price Performance

Historical Comparison
FBGL
XRTX

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply, and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture, as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and sales of construction materials.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

Share on Social Networks: